Full-Time

Clinical Laboratory Scientist

Cls

Updated on 11/19/2024

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$120k - $140kAnnually

+ Equity Options + Corporate Bonus Program

Junior

Hayward, CA, USA

This is an onsite position.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Requirements
  • Bachelor's degree in the chemical, physical or biological sciences
  • 1-2 years of CLS experience in a clinical setting
  • A current California Clinical Laboratory Scientist License that meets requirements for Testing Personnel under CLIA regulations (42 CFR, part 493) (ASCP, CGMBS or generalist license is required).
  • Hands-on training and experience with manual molecular biology protocols, including DNA extraction and PCR
  • Advanced knowledge of Google Docs, Word, Excel, basic statistics and familiarity with LIMS systems
  • Strong attention to detail and ability to work flexibly and well under given timeframes.
  • Self-starter and dynamic team player with excellent verbal and written skills.
Responsibilities
  • Performs clinical laboratory assays to provide data for diagnosis, treatment, and prevention of disease.
  • Performs quality control studies to ensure the accuracy of clinical data.
  • Verifies instrument performance by checking and calibrating specific lab instruments and documents data.
  • Organizes and contributes to R&D to CLIA tech transfer and troubleshooting, training, and validations

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases by identifying minute variations in DNA at a single base-pair level. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to enhance the precision and efficiency of molecular testing, ultimately making a positive impact on healthcare.

Company Stage

Series D

Total Funding

$380.2M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

12%

1 year growth

23%

2 year growth

77%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $130M Series D funding round, led by PremjiInvest, positions BillionToOne for significant growth and expansion.
  • Partnerships with major companies like Johnson & Johnson enhance their credibility and market reach.
  • The appointment of Ross Taylor as CFO brings seasoned financial leadership, supporting the company's hypergrowth trajectory.

What critics are saying

  • The competitive landscape in molecular diagnostics is intense, requiring continuous innovation to maintain a leading position.
  • Dependence on healthcare providers for revenue could be impacted by changes in healthcare policies or economic downturns.

What makes BillionToOne unique

  • BillionToOne's QCT technology offers single base-pair resolution, providing unparalleled accuracy in molecular diagnostics.
  • Their focus on both prenatal screening and oncology testing allows them to address critical healthcare needs with specialized products like Northstar Select™ and Northstar Response™.
  • The company's mission-driven culture and commitment to accessibility set them apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging